Soltis; Daniel A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Soltis; Daniel A..The latest application filed is for "humanized antibodies targeting human tissue factor".

Company Profile

1.9.15

Soltis; Daniel A. - Cleveland Heights OH
Soltis; Daniel A. - Belle Mead NJ
Soltis, Daniel A - Belle Mead NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized antibodies targeting human tissue factor Grant 11,401,345 - Soltis , et al. August 2, 2	2022-08-02
Humanized Antibodies Targeting Human Tissue Factor App 20200385487 - SOLTIS; Daniel A. ; et al.	2020-12-10
Antibodies That Bind Cell-associated Ca 125/o772p App 20190106508 - ALBONE; Earl F. ; et al.	2019-04-11
MHC-I restricted epitopes containing non-natural amino acid residues Grant 10,149,896 - Kyle , et al. Dec	2018-12-11
Antibodies That Bind Cell-Associated CA 125/O772P App 20180105601 - ALBONE; Earl F. ; et al.	2018-04-19
MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues App 20170319670 - KYLE; Donald J. ; et al.	2017-11-09
Antibodies that bind cell-associated CA 125/O772P Grant 9,676,866 - Albone , et al. June 13, 2	2017-06-13
MHC-I restricted epitopes containing non-natural amino acid residues Grant 9,549,972 - Kyle , et al. January 24, 2	2017-01-24
Peptide Immunogens App 20160022787 - KYLE; Donald J. ; et al.	2016-01-28
MHC-I restricted epitopes containing non-natural amino acid residues Grant 9,109,007 - Kyle , et al. August 18, 2	2015-08-18
Antibodies That Bind Cell-associated Ca 125/o772p App 20150094454 - ALBONE; Earl F. ; et al.	2015-04-02
MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues App 20140050749 - Kyle; Donald J. ; et al.	2014-02-20
Antibodies That Bind Cell-associated Ca 125/o772p App 20130281673 - ALBONE; Earl F. ; et al.	2013-10-24
Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772P Grant 8,299,230 - Albone , et al. October 30, 2	2012-10-30
Nucleic Acid Molecules Encoding Antibodies That Bind Cell-Associated CA 125/O772P App 20120149892 - ALBONE; Earl F. ; et al.	2012-06-14
Antibodies that bind cell-associated CA 125/O772P and methods of use thereof Grant 8,124,086 - Albone , et al. February 28, 2	2012-02-28
Antibodies That Bind Cell-associated Ca 125/o772p And Methods Of Use Thereof App 20110158904 - Albone; Earl F. ; et al.	2011-06-30
Antibodies that bind cell-associated CA 125/O772P and methods of use thereof Grant 7,429,382 - Albone , et al. September 30, 2	2008-09-30
Antibodies that bind cell-associated CA 125/O772P and methods of use thereof App 20050064518 - Albone, Earl F. ; et al.	2005-03-24
Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response App 20040143101 - Soltis, Daniel A. ; et al.	2004-07-22
Thrombopoietin(tpo) synthebody for stimulation of platelet production App 20040136980 - Soltis, Daniel A ; et al.	2004-07-15
Anti-idiotype inducing antibodies, comprising at least one epitope from angiodenin, for the inhibition of angiogenesis App 20040030103 - Burch, Ronald ; et al.	2004-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.